Neomycin
Neomycin is a pharmaceutical drug with 18 clinical trials. Currently 2 active trials ongoing. Historical success rate of 90.9%.
Success Metrics
Based on 10 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
5
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
90.9%
10 of 11 finished
9.1%
1 ended early
2
trials recruiting
18
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders
Intestinal Microbiota Transplantation in Patients With Chronic Heart Failure
Do Topical Antibiotics Improve Skin Graft Results?
Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease
Interventional Bioremediation of Microbiota in Metabolic Syndrome
Clinical Trials (18)
Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders
Intestinal Microbiota Transplantation in Patients With Chronic Heart Failure
Do Topical Antibiotics Improve Skin Graft Results?
Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease
Interventional Bioremediation of Microbiota in Metabolic Syndrome
Decolonization of Carbapenem-resistant Enterobacterales (CRE) in Patients With Faecal Carriage of CRE With Neomycin
Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease
Bowel Preparation in Elective Pediatric Colorectal Surgery
Role of Methane in Glycemic Control
Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery
Systems Biology of Flu Vaccine in Healthy Adults With and Without the Use of Antibiotics
Eradication of Antibiotic-resistant Bacteria Through Antibiotics and Fecal Bacteriotherapy
Efficacy of Intestinal Decontamination in Patients Colonized by Carbapenem-resistant Klebsiella Pneumoniae and Colistin
Effect of Neomycin on the Pharmacokinetics of Regorafenib
Neomycin and Rifaximin Plus Neomycin in Treating Methane Positive Constipation Predominant Irritable Bowel Syndrome
Use of Probiotics to Prevent Cholangitis in Children With Biliary Atresia After the Kasai Portoenterostomy
Comparison Between Erythromycin and Neomycin Treatment of Hepatic Encephalopathy
Antibiotics for the Treatment of Ulcerative Colitis
All 18 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 18